Outcome and Summary of the Annual General Meeting held today i.e. 17th September, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Evoq Remedies held its 15th Annual General Meeting on 17th September 2025 via video conferencing, lasting just 8 minutes (4:00 PM to 4:08 PM). The meeting, chaired by Managing Director Bhumishth Patel, was attended by the Statutory Auditor and addressed 11 ordinary resolutions. Key business included adopting the FY25 audited financial statements, re-appointing Mr. Patel (who retires by rotation), and appointing M/s. H Thakkar & Co. LLP as Statutory Auditor. A significant portion of the meeting (8 of 11 resolutions) sought shareholder approval for related-party transactions with multiple group entities, including one material transaction with Poshan Nutriwell Private Limited. Voting results will be announced within two working days.
The e-voting outcomes are still pending, so any immediate stock reaction depends on shareholder approval of the multiple related-party transactions, which minority investors may scrutinize. Re-appointment of the Managing Director and new auditor appointment are routine governance items with no expected price impact.